Pharmaceuticals: Major
Major Bulgarian companies producing pharmaceuticals
Global pharmaceutical corporations develop and distribute prescription medications at a massive scale. Patent expirations, pipeline approvals, and healthcare legislation serve as major catalysts for trading activity and industry liquidity. Market data indicates that Sopharma AD is currently the highest-volume asset, while Pfizer Inc. tops the 24-hour return list. The table below tracks the vital technical and fundamental metrics for these equities.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.19 T EUR | 1,228.4 EUR | −4.60% | 0 | — | 45.72 | 26.87 EUR | +55.94% | 0.47% | Health technology | Strong buy |
 JNJJohnson & Johnson | 592.45 B EUR | 243.05 EUR | −2.88% | 0 | — | 41.77 | 5.82 EUR | −34.10% | 1.91% | Health technology | Buy |
 4ABAbbVie, Inc. | 464.16 B EUR | 258.10 EUR | −3.44% | 0 | — | 50.32 | 5.13 EUR | +354.14% | 2.35% | Health technology | Buy |
 6MKMerck & Co., Inc. | 330.4 B EUR | 131.38 EUR | −3.35% | 0 | — | 151.99 | 0.86 EUR | −86.58% | 2.26% | Health technology | Buy |
 ZEGAstraZeneca PLC | 260.84 B EUR | 165.60 EUR | −3.36% | 0 | — | 26.86 | 6.17 EUR | +16.68% | 1.70% | Health technology | Buy |
 NOVNovo Nordisk A/S Class B | 168.68 B EUR | 35.975 EUR | −1.73% | 16 | 0.52 | 10.58 | 3.40 EUR | +9.26% | 4.10% | Health technology | Neutral |
 PFEPfizer Inc. | 156.31 B EUR | 28.005 EUR | +3.47% | 0 | 0.00 | 45.37 | 0.62 EUR | −57.78% | 5.59% | Health technology | Neutral |
 SNWSanofi SA | 100.88 B EUR | 82.86 EUR | −2.38% | 0 | 0.00 | 24.89 | 3.33 EUR | −35.60% | 4.90% | Health technology | Buy |
 MRKMerck KGaA | 65.41 B EUR | 147.95 EUR | −1.14% | 0 | — | 27.14 | 5.45 EUR | −17.22% | 1.46% | Health technology | Buy |
 BAYNBayer AG | 53.29 B EUR | 54.52 EUR | −3.26% | 0 | 0.00 | — | −1.77 EUR | +49.15% | 0.20% | Health technology | Buy |
 ZOEZoetis, Inc. Class A | 32.83 B EUR | 76.60 EUR | +0.21% | 0 | — | 14.39 | 5.32 EUR | +7.88% | 2.38% | Health technology | Neutral |
 KN8Krka, d. d., Novo mesto | 7.73 B EUR | 244.0 EUR | −2.01% | 0 | — | 17.73 | 13.77 EUR | +10.70% | 3.67% | Health technology | Buy |
 SFASopharma AD | 1.68 B EUR | 3.33 EUR | +0.91% | 16.3 K | 0.36 | 22.29 | 0.15 EUR | +52.60% | 2.97% | Health technology | No rating |
 PHRMPharmhold AD | — | 0.540 EUR | 0.00% | 0 | — | — | — | — | — | Health technology | No rating |